Pediatric Normative Movement Analysis Data Collection

NCT04638595 | Completed

• 1 other identifier: Normative Data Study
• Study Type: observational
• Target: 50
• Locations: 1 country
• Sites: 1

Brief Summary

The objective of this project is to collect baseline data from a normative population of children that gender and age matches the population of patients expected to be treated by Mary Bridge Children's Therapy Services and seen in the Research and Movement Laboratory. This project seeks to recruit 25 male and 25 female typically developing children between the ages of 3 and 18 years of age. Non-invasive measurements of movement patterns will be collected during common activities of daily living over a single data collection session.

Conditions

Pediatric ALL

Outcome Measures

Primary Outcomes (1)

• Create normative baseline data for typically developing children

  Establishing a baseline of pediatric biomechanics is an important step in performing the best possible analyses for our patients. Normative data provides that baseline, and provides the data to explore links within the dense, interconnected behavior of human motion.

  1 year

Study Arms (1)

Normative

50 neurotypical pediatric subjects

Other: Observation

Interventions

Observation OTHER

This project seeks to recruit 25 male and 25 female typically developing children between the ages of 3 and 18 years of age. Non-invasive measurements of movement patterns will be collected during common activities of daily living over a single data collection session.

Normative

Eligibility Criteria

• Age: 3 Years - 18 Years
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Child (0-17), Adult (18-64)
• Sampling Method: Non-Probability Sample

Study Population

A group of 50 neurotypical pediatric subjects will be recruited for this data collection. Children will be assigned to 1 of 5 age groupings (3-5, 6-8, 9-11, 12-14, 15-18), with an equal amount of male/female in each.

You may qualify if:

• Age between 3-18 years
• Ambulate independently and without the use of assistive devices
• Perform activities of daily living without physical assistance
• Tolerate adhesive markers placed on skin and clothing
• Willing and interested in participating

You may not qualify if:

• Neuromuscular disorders such as cerebral palsy, muscular dystrophy, myotonic dystrophy, spinal muscular atrophy, peripheral neuropathy, or other generalized muscle and/or nerve issues
• Evidence of developmental delays, muscle weakness, decreased muscle tone, joint stiffness, muscle or bone deformity
• Currently using or has a history of using assistive technology devices, bracing/orthoses, manual or powered mobility equipment
• Was born pre-term
• Currently or has a history of taking medication or pharmaceutical treatment related to musculoskeletal side-effects/scenario/diagnosis

Sponsors & Collaborators

• MultiCare Health System Research Institute: lead

Study Sites (1)

Mary Bridge Children's Therapy Unit

Puyallup, Washington, 98372, United States

Location

MeSH Terms

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma

Interventions

Observation

Condition Hierarchy (Ancestors)

Leukemia, Lymphoid; Leukemia; Neoplasms by Histologic Type; Neoplasms; Hematologic Diseases; Hemic and Lymphatic Diseases; Lymphoproliferative Disorders; Lymphatic Diseases; Immunoproliferative Disorders; Immune System Diseases

Intervention Hierarchy (Ancestors)

Methods; Investigative Techniques

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: CROSS SECTIONAL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: November 16, 2020
• First Posted: November 20, 2020
• Study Start: November 16, 2020
• Primary Completion: May 5, 2021
• Study Completion: May 5, 2021
• Last Updated: August 5, 2022

Record last verified: 2022-08

Data Sharing

• IPD Sharing: Will not share

Locations

US (1)